May 26, 2017
Cardiovascular disease has become the leading cause of death worldwide, accounting for 31% of all deaths, or 17.5 million fatalities, globally in 2012, according to WHO.
In 2016 USPSTF released guidelines recommending statin use for the primary prevention of cardiovascular disease in adults. However, many experts have argued that addressing upstream causes of cardiovascular disease might be a better option. Especially since in some patients, statins cause side effects ranging from muscle achiness to gastrointestinal distress, liver toxicity and even rhabdomyolysis, a potentially life threatening breakdown of muscle tissue.